000 01610 a2200493 4500
005 20250517045957.0
264 0 _c20161019
008 201610s 0 0 eng d
022 _a1878-0261
024 7 _a10.1016/j.molonc.2015.07.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe Marchi, Tommaso
245 0 0 _a4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
_h[electronic resource]
260 _bMolecular oncology
_cJan 2016
300 _a24-39 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xclassification
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aTamoxifen
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aLiu, Ning Qing
700 1 _aStingl, Cristoph
700 1 _aTimmermans, Mieke A
700 1 _aSmid, Marcel
700 1 _aLook, Maxime P
700 1 _aTjoa, Mila
700 1 _aBraakman, Rene B H
700 1 _aOpdam, Mark
700 1 _aLinn, Sabine C
700 1 _aSweep, Fred C G J
700 1 _aSpan, Paul N
700 1 _aKliffen, Mike
700 1 _aLuider, Theo M
700 1 _aFoekens, John A
700 1 _aMartens, John W M
700 1 _aUmar, Arzu
773 0 _tMolecular oncology
_gvol. 10
_gno. 1
_gp. 24-39
856 4 0 _uhttps://doi.org/10.1016/j.molonc.2015.07.004
_zAvailable from publisher's website
999 _c25181125
_d25181125